Get the Stockscreener App
1.37
0.74%
0.01
After Hours:
1.32
-0.05
-3.65%
Barinthus Biotherapeutics Plc Adr stock is traded at $1.37, with a volume of 52,284.
It is up +0.74% in the last 24 hours and up +30.48% over the past month.
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.
See More
Previous Close:
$1.36
Open:
$1.33
24h Volume:
52,284
Relative Volume:
0.04
Market Cap:
$55.78M
Revenue:
$13.42M
Net Income/Loss:
$-73.35M
P/E Ratio:
-0.7135
EPS:
-1.92
Net Cash Flow:
$-56.34M
1W Performance:
-9.27%
1M Performance:
+30.48%
6M Performance:
+101.17%
1Y Performance:
+14.17%
1-Day Range:
$1.20
$1.41
1-Week Range:
$1.20
$1.505
52-Week Range:
$0.64
$2.92
Barinthus Biotherapeutics Plc Adr Stock (BRNS) Company Profile
Name
Barinthus Biotherapeutics Plc Adr
Sector
Industry
Phone
44 (0) 1865 818808
Address
20400 CENTURY BLVD, GERMANTOWN
Compare BRNS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BRNS
Barinthus Biotherapeutics Plc Adr
|
1.37 | 55.53M | 13.42M | -73.35M | -56.34M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.90 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
470.27 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.42 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
815.61 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
316.15 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Barinthus Biotherapeutics Plc Adr Stock (BRNS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-25-21 | Initiated | Jefferies | Buy |
| May-25-21 | Initiated | Morgan Stanley | Overweight |
| May-25-21 | Initiated | William Blair | Outperform |
| May-24-21 | Initiated | H.C. Wainwright | Buy |
Barinthus Biotherapeutics Plc Adr Stock (BRNS) Latest News
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Barinthus Biotherapeutics plc (NASDAQ: BRNS) - GlobeNewswire Inc.
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates ETNB, TRML, CORZ, BRNS on Behalf of Shareholders - Barchart.com
BARINTHUS BIOTHERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Barinthus Biotherapeutics plcBRNS - The Globe and Mail
Morning Market Movers: DBVT, CLPT, DWTX, Seeing Big Swings - RTTNews
Barinthus Biotherapeutics (NASDAQ:BRNS) Shares Down 15.5% – Here’s Why - Defense World
Short Interest in Barinthus Biotherapeutics PLC Sponsored ADR (NASDAQ:BRNS) Grows By 498.5% - MarketBeat
BRNS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Barinthus Biotherapeutics plc Is Fair to Shareholders - The Globe and Mail
Barinthus Bio and Clywedog to merge in all-stock deal - Investing.com
37,450 Shares in Barinthus Biotherapeutics PLC Sponsored ADR $BRNS Acquired by HighTower Advisors LLC - Defense World
Raymond James Financial Inc. Raises Stock Position in Virtus Terranova U.S. Quality Momentum ETF $JOET - Defense World
Freehold Royalties (TSE:FRU) Stock Price Crosses Above Two Hundred Day Moving Average – What’s Next? - Defense World
Colombia Energy Resources (OTCMKTS:CERX) Stock Crosses Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
PNC Financial Services Group Inc. Increases Stake in United Microelectronics Corporation (NYSE:UMC) - Defense World
BRNS’s Market Whiplash: 50.99% YTD Rise, 152.41% Rise in 30 Days - investchronicle.com
BRNS stock touches 52-week low at $0.8 amid market volatility - Investing.com
Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Strong Buy: Here's Why - Nasdaq
Barinthus Bio shifts focus, cuts workforce to extend cash runway - Investing.com
Mexico Shingles Vaccine Market Size & Outlook, 2023-2030 - Grand View Research
Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket - Investing.com UK
Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Most Volatile Stocks, What Investors Need to Know - MarketBeat
What Investors Need to Know to Beat the Market - MarketBeat
Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time - MarketBeat
Barinthus Biotherapeutics Plc Adr Stock (BRNS) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.09%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):